Radiopharmaceutical Bioanalysis
Advanced bioanalysis solutions for radiopharmaceutical drug and therapy development.
- Services
- Radiopharmaceutical Bioanalysis
Radiopharmaceutical Bioanalysis Solutions
For over 15 years, our GMP and GLP-accredited radiopharmaceutical facility in Turku, Finland (registered with the Finnish Radiation and Nuclear Safety Authority – STUK) has been providing radiobiological services including full radioactive sample management, radioimmunoassay method development & validation, clinical sample analysis, and more to advance customers’ radiopharmaceutical drug development.
Adhering strictly to regulatory standards for safety and efficacy, our team is licensed and experienced in handling a variety of key isotopes including Ac-225, Th-227, H-3, I-125, and I-131. We can also work with a wide range of other radioactive substances with expedited approval from Finnish authorities to meet sponsor needs.
Our Radiopharmaceutical Services:
- Sample Management
Our facility is fully capable of receiving and storing radioactive samples. Samples are recorded and monitored for total radioactivity.
- PK Sample Analysis
Multi-step approach using immunological and cell-based techniques for pharmacokinetic (PK) sample analysis.
- Immunogenicity Testing
Plate and cell-based technologies to assess the immunogenicity of biological drugs and vaccines.
- Assays & Platforms
Our expert team harnesses various assays and platforms for GMP/PK Analysis and Immunogenicity testing, including:
- ECL (MSD)
- Gyrolab
- ELISA
- SPR (Biacore)
- TR-FIA (Delfia) & TR-FRET
- AlphaScreen/AlphaLISA
- Cell-based assays
- Radioimmunoassays (RIA)
- Wizard2 gammacounters
- LC-MS/MS
Learn more in our webinar:
Gammacounting Technology
Combining outstanding sensitivity together with high-level security, connectivity and ease of use, the Wizard2® is Synexa’s gammacounting instrument of choice for radiopharmaceutical bioanalysis.
